VFEND
- Product NDC
- 55154-2725
- 11-digit product format
- 551542725
- Labeler code
- 55154
- Product ID
- 55154-2725_c9a9b2de-dae1-411c-a13e-8b445ff993ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- voriconazole
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Cardinal Health
- Application
- NDA021266
- Marketing category
- NDA
- Marketing start
- 2002-05-24
- Marketing end
- 0000-00-00
- Substance
- VORICONAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record